SPOTLIGHT: Is the NHS really cutting drug spending by 10%?

by admin |

U.K. officials are pooh-poohing reports that they intend to cut drug spending by 10 percent with a new pharma contract now under negotiation. Report

Suggested Articles

name tag
Pharma

Say hello to Viatris: Pfizer's Upjohn, Mylan merger gets a name

Mylan and Pfizer's Upjohn have a name for their pending merger: Viatris. Heard that before? So has Mylan, which owns a subsidiary with the same name.

by Kyle Blankenship
Test tubes
Pharma

Noninvasive tests can advance NASH diagnostics: analysis

Intercept presented a data analysis that found treatment with Ocaliva led to "early and consistent improvements" in a range of noninvasive tests.

by Amirah Al Idrus
Amarin Vascepa pill
Pharma

FDA panel to scrutinize placebo in Amarin's Vascepa trial

Days before Amarin faces a pivotal FDA vote on its Vascepa expansion, advisors are set to scrutinize the placebo used in its pivotal outcomes trial.

by Kyle Blankenship